NovaBridge Biosciences Share Price
NASDAQ: NBPNovaBridge Biosciences Stock Performance
NovaBridge Biosciences Share Price Today
As of 31 October 2026, NovaBridge Biosciences's share price is $1.20. The stock opened at $1.21, compared to its previous close of $1.22. During today's trading session, NovaBridge Biosciences's share price traded between $1.16 and $1.21, with an average price of $1.18. Over the past 52 weeks, the stock has recorded a high of $5.17 and a low of $1.16. In terms of performance, NovaBridge Biosciences's share price has declined by 51.02% over the last six months and is down 75.54% on a year-on-year basis.
NovaBridge Biosciences Share Price Chart
About NovaBridge Biosciences
NovaBridge Biosciences operates as a biotechnology platform, combining business development and clinical research to identify and advance pharmaceutical assets. Its inventive immuno-oncology pipeline consists of three clinical stage programs, givastomig; uliledlimab; and ragistomig. Its core product, givastomig, is a potential in-class CLDN18.2 bispecific antibody for the treatment of gastric cancer and other CLDN18.2-positive gastrointestinal malignancies.
NovaBridge Biosciences Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $1.38 | $1.20 | -12.09% |
Sep 2026 | $1.82 | $1.36 | -28.16% |
Aug 2026 | $1.63 | $1.90 | +18.75% |
Jul 2026 | $1.92 | $1.60 | -18.37% |
Jun 2026 | $1.80 | $1.96 | +6.52% |
May 2026 | $2.43 | $1.84 | -24.90% |
Apr 2026 | $2.51 | $2.45 | -0.41% |
Mar 2026 | $3.21 | $2.46 | -24.77% |
Feb 2026 | $3.25 | $3.27 | -1.21% |
Jan 2026 | $4.17 | $3.31 | -16.62% |
Dec 2025 | $3.83 | $3.97 | +3.39% |
Nov 2025 | $5.10 | $3.84 | -21.71% |